Discontinuation of methotrexate treatment in juvenile rheumatoid arthritis

Pediatrics

Volumn 100, Issue 6, 1997, Pages 994-997

  Gottlieb, Beth S ^a   Keenan, Gregory F ^b   Lu, Theresa ^b   Ilowite, Norman T ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Juvenile rheumatoid arthritis; Methotrexate; Remission relapse

Indexed keywords

METHOTREXATE;

ADOLESCENT; ARTICLE; CHILD; DISEASE CONTROL; DISEASE COURSE; DOSE RESPONSE; DRUG WITHDRAWAL; FEMALE; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; RELAPSE; REMISSION; RETROSPECTIVE STUDY;

EID: 0030691911     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.100.6.994     Document Type: Article

References (26)

1. Giannini EH, Brewer EJ, Kuzmina N, et al. Methotrexate in resistant juvenile rheumatoid arthritis. Results of the USA-USSR double-blind, placebo-controlled trial. N Engl J Med. 1992;326:1043-1049
2. Giannini EH, Brewer EJ, Kuzmina N, et al. Auranofin in the treatment of juvenile rheumatoid arthritis. Results of the USA-USSR double-blind, placebo-controlled trial. Arthritis Rheum. 1990;33:466-476
3. Wallace CA, Levinson JE. Juvenile rheumatoid arthritis: outcome and treatment for the 1990s. Rheum Dis Clin North Am. 1991;17:891-905
4. Tucker LB. Juvenile rheumatoid arthritis. Curr Opin Rheumatol. 1993;5: 619-628
5. Schneider R, Lang BA, Reilly BJ, et al. Prognostic indicators of joint destruction in systemic-onset juvenile rheumatoid arthritis. J Pediatr. 1992;120:200-205
6. Rose CD, Singsen BH, Eichenfeld AH, et al. Safety and efficacy of methotrexate therapy for juvenile rheumatoid arthritis. J Pediatr. 1990; 117:653-659
7. Kujala GA, Shamma'a JM, Chang WL, et al. Hepatitis with bridging fibrosis and reversible hepatic insufficiency in a woman with rheumatoid arthritis taking methotrexate. Arthritis Rheum. 1990;33:1037-1041
8. Graham LD, Myones BL, Rivas-Charcon RF, Pachman LM. Morbidity associated with long-term methotrexate treatment in JRA. J Pediatr. 1992;120:468-473
9. Martini A, Ravelli A, Viola S, Burgio GR. Methotrexate hepatotoxic effects in children with juvenile rheumatoid arthritis. J Pediatr. 1991;119: 333-334
10. Keim D, Ragsdale C, Heidelberger K, Sullivan D. Hepatic fibrosis with the use of methotrexate for juvenile rheumatoid arthritis. J Rheumatol. 1990;17:846-848
11. van-der-Veen MJ, van der Heide A, Kruize AA, et al. Infection rate and use of antibiotics in patients with rheumatoid arthritis treated with methotrexate. Ann Rheum Dis. 1994;53:224-228
12. Tsai JJ, Shin JF, Chen CH, et al. Methotrexate pneumonitis in bronchial asthma. Int Arch Allergy Immunol. 1993;100:287-290
13. Liote F, Pertuiset E, Cochand-Priollet B, et al. Methotrexate-related B lymphoproliferative disease in a patient with rheumatoid arthritis. Role of Epstein-Barr virus infection. J Rheumatol. 1995;22:1174-1178
14. Zimmer-Galler I, Lie JT. Choroidal infiltrates as the initial manifestation of lymphoma in rheumatoid arthritis after treatment with low-dose methotrexate. Mayo Clin Proc. 1994;69:258-261
15. Kremer J, Rynes RI, Bartholomew LE. Severe flare of rheumatoid arthritis after discontinuation of long-term methotrexate therapy. Am J Med. 1987;82:781-786
16. Ravelli A, Stefania V, Ramenghi B, et al. Frequency of relapse after discontinuation of methotrexate therapy for clinical remission in juvenile rheumatoid arthritis. J Rheumatol. 1995;22:1574-1576
17. Brewer EJ Jr, Bass JC, Cassidy JT, et al. Criteria for the classification of juvenile rheumatoid arthritis. Bull Rheum Dis. 1972;23:712-719
18. Brewer EJ, Bass JC, Baum J, et al. Current proposed revision of juvenile rheumatoid arthritis criteria. Arthritis Rheum. 1976;20:195-199
19. Zachariae H, Kragballe K, Sogaard H. Methotrexate-induced liver cirrhosis. Studies including serial liver biopsies during continued treatment. Br J Dermatol. 1980;102:407-412
20. Robinson JK, Baughman RD, Auerbach R. Methotrexate hepatotoxicity in psoriasis. Consideration of liver biopsies at regular intervals. Arch Dermatol 1980;102:407-412
21. Wallace CA, Sherry DD, Mellins ED, Aiken RP. Predicting remission in juvenile rheumatoid arthritis with methotrexate treatment. J Rheumatol. 1993;20:118-122
22. Hanson V, Kornreich H, Bernstein B, et al. Prognosis of juvenile rheumatoid arthritis. Arthritis Rheum. 1977;20:279-284
23. Calabro JJ, Marchesano JM. The early natural history of juvenile rheumatoid arthritis. A ten-year follow-up study of 100 cases. Med Clin North Am. 1968;52:567-591
24. Calabro JJ, Holgerson WB, Sonpal GM, et al. Juvenile rheumatoid arthritis: a general review and report of 100 patients observed for 15 years. Semin Arthritis Rheum. 1976;5:257-298
25. Ansell BM, Wood PHN. Prognosis in juvenile chronic polyarthritis. Clin Rheum Dis. 1976;2:397-412
26. Cassidy JT, Levinson JC, Bass J, et al. A study of classification criteria for a diagnosis of juvenile rheumatoid arthritis. Arthritis Rheum. 1986;29: 274-281